News

Under the collaboration, Novo Nordisk will fund 10 Oxford researchers at the Kennedy Institute of Rheumatology to work within the partnership. A Joint steering committee with members from

The randomized, double-blind study will evaluate the efficacy, safety, and tolerability of blisibimod administration in subjects with systemic lupus erythematosus. The clinical improvement at 24 weeks in an

The adverse events after intravenous administration of solutions containing particulates may include disruption of blood flow within small blood vessels in the lung, localized inflammation (swelling and redness),

The collaboration begins with a US co-promotion for AstraZeneca’s oral antiplatelet medicine BRILINTA, under which The Medicines Company sales force will begin supporting the product in May 2012.

The once-monthly erythropoiesis-stimulating agent (ESA) for anemia is co-marketed by Affymax and Takeda Pharmaceuticals USA (TPUSA) and distributed by TPUSA. Affymax chief executive officer John Orwin said, "Today’s

The Drug Controller General of India approved the new drug, indicated for relief from malaria-related symptoms, for marketing in India. Ranbaxy CEO and managing director Arun Sawhney said

In January 2007, Boehringer and Ablynx entered into research and licensing agreement to discover new therapies for Alzheimer’s disease. The nanobody, developed under the collaboration, triggered a €1m

The new Web-based version is fully compatible with the company’s legacy IRMS software, and allows the company’s service representatives to easily capture and respond to medical information requests

PRC Clinical will incorporate SimpleCTMS into their suite of eClinical services to carry out a full suite of clinical services while maintaining level of quality standards. PRC Clinical